Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Versus Standard of Care Antibiotic Duration for Hospitalized Children With Uncomplicated Community-acquired Pneumonia
NCT06494072Phase 4Recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- Aug 2024
- Primary completion
- May 2028
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of ampicillin, ceftriaxone, amoxicillin, ampicillin + sulbactam, amoxicillin + clavulanate in community acquired pneumonia (CAP), sponsored by Medical College of Wisconsin. Started Aug 2024; status: recruiting.
02
Drugs
ampicillinceftriaxoneamoxicillinampicillin + sulbactamamoxicillin + clavulanate
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT06494072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06494072.